Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02407301
Other study ID # IRB201400733
Secondary ID
Status Completed
Phase N/A
First received March 30, 2015
Last updated May 11, 2016
Start date April 2015
Est. completion date February 2016

Study information

Verified date May 2016
Source University of Florida
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This project is a first attempt to assess cough airflow dynamics and true vocal fold (TVF) adduction and abduction angles during voluntary cough to examine the effects of changes in glottal closure due to reduced mobility of one true vocal fold. The hypothesis of this study is that the incomplete glottal closure due to reduced vocal fold mobility will result in changes in true vocal fold adductory and abductory angles during cough and will result in changes to voluntary cough airflow parameters. This study results will contribute to the existing knowledge of the laryngeal contribution to cough airflow dynamics.


Description:

The study investigators will consecutively recruit 30 adults diagnosed with vocal fold insufficiency due to reduced mobility of one true vocal fold.

A questionnaire will be used to collect participants' information. Demographic information such as age, gender, race/ethnicity, height, weight, and a major complaint (dysphonia and/or dysphagia) and medical history information determining the eligibility for participation will be collected from the participant. Participant's medical and surgical history specifically related to the diagnosis and the etiology of reduced vocal fold mobility will be obtained from the participant's medical record.

Videolaryngoscopy will be performed as part of standard clinical care. Vocal fold image and cough airflow will be recorded simultaneously during voluntary cough production with the flexible endoscope in nasopharynx. A second part of the study will include spirometry and expiratory muscle strength assessments. Video images of the vocal fold movement during vowel phonation and cough production will be recorded and stored on a CD for later analysis. The cough airflow recordings will be displayed, stored, and analyzed using LabChart software for Windows.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date February 2016
Est. primary completion date February 2016
Accepts healthy volunteers No
Gender Both
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria:

1. Age between 40 and 75 years.

2. Glottal insufficiency secondary to reduced TVF mobility confirmed with the endoscopic evaluation performed by an otolaryngologist.

3. The ability to provide informed consent.

4. No history of chronic obstructive pulmonary disease, lung cancer, and/or lung transplant.

5. No history of neurodegenerative disease such as Parkinson's disease, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or progressive supranuclear palsy (PSP), Alzheimer's disease, or dementia.

Exclusion Criteria:

1. Chest infection within one month prior to the study participation.

2. History of the adverse reaction associated with laryngoscopy.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Intervention

Other:
cough airflow measure
Participants will produce multiple voluntary coughs for cough airflow assessment.
vocal tasks
The assessment of glottal closure will be performed during phonation tasks.
true vocal fold movement
The true vocal fold (TVF) movement in cough will be observed and recorded during cough production.
spirometry test
The lung function test will require the participant to perform deep inhalations and forceful exhalations into the flow head of the spirometer during spirometry test.
maximum expiratory pressure (MEP)
The assessment of maximum expiratory pressure will require forceful exhalations into a mouthpiece of a manometer during maximum expiratory pressure (MEP) assessment.

Locations

Country Name City State
United States University of Florida ENT Clinic Gainesville Florida
United States University of Florida Speech and Hearing Center Gainesville Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Florida

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peak expiratory flow rate (PEFR) Maximum flow rate in expiratory phase, expressed in liters per second (L/s) baseline No
Primary True vocal fold maximum abduction angles in inspiratory phase The TVF maximum abduction angles during cough inspiratory phase of cough will be expressed in degrees. baseline No
Primary True vocal fold maximum abduction angles in expiratory phase True vocal fold maximum abduction angles in expiratory phase of cough will be expressed in degrees. baseline No
Primary True vocal fold maximum adduction angles in compression phase True vocal fold maximum adduction angles in compression phase of cough will be expressed in degrees. baseline No
Primary Peak expiratory flow rise time (PEFRT) Time to reach peak expiratory flow rate expressed in seconds baseline No
Primary Cough volume acceleration (CVA) A ratio of peak expiratory flow rate and peak expiratory flow rise time expressed in L/s/s baseline No
Primary Expiratory phase duration Duration of expiratory phase of cough expressed in seconds baseline No
Secondary Peak expiratory flow Maximum flow rate during forced exhalation expressed in L/s baseline No
Secondary Maximum expiratory pressure Maximum expiratory pressure will be expressed in cmH2O. baseline No
Secondary Degree of glottal closure The degree of glottal closure will be assessed during phonation using glottic closure rating scale 1-6, 1=complete closure, 6=incomplete closure all along the vocal folds (Södersten et al., 1990). baseline No
Secondary Forced vital capacity (FVC) Maximum amount of air that can be exhaled with maximal speed and effort after maximum inhalation, expressed in L baseline No
Secondary Forced expired volume within 1 second (FEV1) Maximum amount of air exhaled forcefully within 1 second, expressed in L. baseline No
Secondary The ratio FEV1/FVC The percent (%) of forcefully exhaled air that can be exhaled during the first second of exhalation. baseline No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03692494 - The Effects of Adding Expiratory Muscle Strength Training in Voice Therapy N/A
Terminated NCT00064571 - Surgery for Vocal Cord Paralysis Phase 3
Completed NCT03906877 - Early UVFP Management Based on Neurological Evidences (UVFP = Unilateral Vocal Fold Paralysis) N/A
Completed NCT03966183 - Early UVFP Management Based on Neurological Evidences (ION-UVFP) - Preliminary Study
Recruiting NCT02243722 - Establish Quantitative Measurements of Laryngeal Sensorimotor Functions and Evaluating the Grade of Phonation and Swallowing Impairment N/A
Completed NCT00597844 - Improving Functional Outcomes in Patients With Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging N/A
Recruiting NCT05963165 - Non-phonatory Exercises in Patients With Unilateral Vocal Fold Paralysis Post-thyroidectomy N/A
Enrolling by invitation NCT02184377 - The Function of Cricothyroid Muscle and Its Impaction on Mandarin Lexical Tones in Unilateral Vocal Fold Paralysis Phase 0